High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion

Robert T Dorr, M. S. Dordal, L. M. Koenig, C. W. Taylor, T. M. McCloskey

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A 56-year-old patient with multiple myeloma experienced an extravasation of doxorubicin (DOX) and vincristine administered as a 96-hour infusion. An unknown quantity of solution (2.1 mg/ml of DOX and 0.1 mg/ml of vincristine) extravasated into the medial aspect of the right upper arm. This was caused by the axillary blockage of a 14-inch, 18-gauge catheter that had been inserted through the anticubital fossa. The only physical complaint mentioned by the patient was a dull muscle ache. No local swelling or redness was apparent until 2 weeks after the extravasation occurred, at which time surgical debridement yielded a 9.2 x 4 x 2-cm section of fascia and thrombosed vein with a normal-appearing margin. A high performance liquid chromatography analysis of different tissue areas in the surgical specimen yielded DOX levels of 1.25 to 7.94 μg/g of wet tissue weight. These levels are approximately tenfold higher than those of any previous extravasation reports. Slightly lower levels of the DOX aglycone (but no doxorubicinol) were recovered from these tissues. An important finding was the DOX level of 2.7 μg/g in the margin of the specimen, predicting a need for further surgery. Indeed, a second debridement was performed 1 week later, followed by a split thickness skin graft. Although the myeloma remains in clinical remission, use of the effected right arm is limited primarily by skin contracture at the graft site. This case demonstrates that high DOX levels can be deposited in soft tissues during prolonged DOX infusions without producing severe acute symptomatology. Furthermore, an analysis of DOX content in excised tissues may help guide the surgical management of the patient experiencing an extravasation.

Original languageEnglish (US)
Pages (from-to)2462-2464
Number of pages3
JournalCancer
Volume64
Issue number12
DOIs
StatePublished - 1989

Fingerprint

Doxorubicin
Vincristine
Debridement
Arm
Transplants
Skin
Fascia
Contracture
Multiple Myeloma
Veins
Thrombosis
Catheters
High Pressure Liquid Chromatography
Weights and Measures
Pain
Muscles

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion. / Dorr, Robert T; Dordal, M. S.; Koenig, L. M.; Taylor, C. W.; McCloskey, T. M.

In: Cancer, Vol. 64, No. 12, 1989, p. 2462-2464.

Research output: Contribution to journalArticle

Dorr, Robert T ; Dordal, M. S. ; Koenig, L. M. ; Taylor, C. W. ; McCloskey, T. M. / High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion. In: Cancer. 1989 ; Vol. 64, No. 12. pp. 2462-2464.
@article{056e94ee9c754ffbae01a67f1734fe88,
title = "High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion",
abstract = "A 56-year-old patient with multiple myeloma experienced an extravasation of doxorubicin (DOX) and vincristine administered as a 96-hour infusion. An unknown quantity of solution (2.1 mg/ml of DOX and 0.1 mg/ml of vincristine) extravasated into the medial aspect of the right upper arm. This was caused by the axillary blockage of a 14-inch, 18-gauge catheter that had been inserted through the anticubital fossa. The only physical complaint mentioned by the patient was a dull muscle ache. No local swelling or redness was apparent until 2 weeks after the extravasation occurred, at which time surgical debridement yielded a 9.2 x 4 x 2-cm section of fascia and thrombosed vein with a normal-appearing margin. A high performance liquid chromatography analysis of different tissue areas in the surgical specimen yielded DOX levels of 1.25 to 7.94 μg/g of wet tissue weight. These levels are approximately tenfold higher than those of any previous extravasation reports. Slightly lower levels of the DOX aglycone (but no doxorubicinol) were recovered from these tissues. An important finding was the DOX level of 2.7 μg/g in the margin of the specimen, predicting a need for further surgery. Indeed, a second debridement was performed 1 week later, followed by a split thickness skin graft. Although the myeloma remains in clinical remission, use of the effected right arm is limited primarily by skin contracture at the graft site. This case demonstrates that high DOX levels can be deposited in soft tissues during prolonged DOX infusions without producing severe acute symptomatology. Furthermore, an analysis of DOX content in excised tissues may help guide the surgical management of the patient experiencing an extravasation.",
author = "Dorr, {Robert T} and Dordal, {M. S.} and Koenig, {L. M.} and Taylor, {C. W.} and McCloskey, {T. M.}",
year = "1989",
doi = "10.1002/1097-0142(19891215)64:12<2462::AID-CNCR2820641211>3.0.CO;2-9",
language = "English (US)",
volume = "64",
pages = "2462--2464",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion

AU - Dorr, Robert T

AU - Dordal, M. S.

AU - Koenig, L. M.

AU - Taylor, C. W.

AU - McCloskey, T. M.

PY - 1989

Y1 - 1989

N2 - A 56-year-old patient with multiple myeloma experienced an extravasation of doxorubicin (DOX) and vincristine administered as a 96-hour infusion. An unknown quantity of solution (2.1 mg/ml of DOX and 0.1 mg/ml of vincristine) extravasated into the medial aspect of the right upper arm. This was caused by the axillary blockage of a 14-inch, 18-gauge catheter that had been inserted through the anticubital fossa. The only physical complaint mentioned by the patient was a dull muscle ache. No local swelling or redness was apparent until 2 weeks after the extravasation occurred, at which time surgical debridement yielded a 9.2 x 4 x 2-cm section of fascia and thrombosed vein with a normal-appearing margin. A high performance liquid chromatography analysis of different tissue areas in the surgical specimen yielded DOX levels of 1.25 to 7.94 μg/g of wet tissue weight. These levels are approximately tenfold higher than those of any previous extravasation reports. Slightly lower levels of the DOX aglycone (but no doxorubicinol) were recovered from these tissues. An important finding was the DOX level of 2.7 μg/g in the margin of the specimen, predicting a need for further surgery. Indeed, a second debridement was performed 1 week later, followed by a split thickness skin graft. Although the myeloma remains in clinical remission, use of the effected right arm is limited primarily by skin contracture at the graft site. This case demonstrates that high DOX levels can be deposited in soft tissues during prolonged DOX infusions without producing severe acute symptomatology. Furthermore, an analysis of DOX content in excised tissues may help guide the surgical management of the patient experiencing an extravasation.

AB - A 56-year-old patient with multiple myeloma experienced an extravasation of doxorubicin (DOX) and vincristine administered as a 96-hour infusion. An unknown quantity of solution (2.1 mg/ml of DOX and 0.1 mg/ml of vincristine) extravasated into the medial aspect of the right upper arm. This was caused by the axillary blockage of a 14-inch, 18-gauge catheter that had been inserted through the anticubital fossa. The only physical complaint mentioned by the patient was a dull muscle ache. No local swelling or redness was apparent until 2 weeks after the extravasation occurred, at which time surgical debridement yielded a 9.2 x 4 x 2-cm section of fascia and thrombosed vein with a normal-appearing margin. A high performance liquid chromatography analysis of different tissue areas in the surgical specimen yielded DOX levels of 1.25 to 7.94 μg/g of wet tissue weight. These levels are approximately tenfold higher than those of any previous extravasation reports. Slightly lower levels of the DOX aglycone (but no doxorubicinol) were recovered from these tissues. An important finding was the DOX level of 2.7 μg/g in the margin of the specimen, predicting a need for further surgery. Indeed, a second debridement was performed 1 week later, followed by a split thickness skin graft. Although the myeloma remains in clinical remission, use of the effected right arm is limited primarily by skin contracture at the graft site. This case demonstrates that high DOX levels can be deposited in soft tissues during prolonged DOX infusions without producing severe acute symptomatology. Furthermore, an analysis of DOX content in excised tissues may help guide the surgical management of the patient experiencing an extravasation.

UR - http://www.scopus.com/inward/record.url?scp=0024814305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024814305&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19891215)64:12<2462::AID-CNCR2820641211>3.0.CO;2-9

DO - 10.1002/1097-0142(19891215)64:12<2462::AID-CNCR2820641211>3.0.CO;2-9

M3 - Article

C2 - 2819656

AN - SCOPUS:0024814305

VL - 64

SP - 2462

EP - 2464

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -